Combination Nanomedicine Strategy for Preventing High-Risk Corneal Transplantation Rejection.
Saved in:
| Title: | Combination Nanomedicine Strategy for Preventing High-Risk Corneal Transplantation Rejection. |
|---|---|
| Authors: | Meng T; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States., Zheng J; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States.; Department of Ophthalmology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China., Shin CS; Michale E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States., Gao N; Departments of Ophthalmology, Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States., Bande D; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States., Sudarjat H; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States., Chow W; Department of Ophthalmology, Virginia Commonwealth University, Richmond, Virginia 23298, United States.; Department of Pathology, Virginia Commonwealth University, Richmond, Virginia 23298, United States., Halquist MS; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States., Yu FS; Departments of Ophthalmology, Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States., Acharya G; Michale E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States.; Department of Materials Science and Nanoengineering, Rice University, Houston, Texas 77005, United States., Xu Q; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298, United States.; Department of Ophthalmology, Virginia Commonwealth University, Richmond, Virginia 23298, United States.; Center for Pharmaceutical Engineering; Institute for Structural Biology, Drug Discovery & Development (ISB3D); and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, United States. |
| Source: | ACS nano [ACS Nano] 2024 Jul 29. Date of Electronic Publication: 2024 Jul 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-086X (Electronic) Linking ISSN: 19360851 NLM ISO Abbreviation: ACS Nano Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
